In 2019, approximately 19% of adult patients who were diagnosed with mental-health disorders received treatment for these disorders.
This progressive pulmonary disorder, with an increasing prevalence affecting individuals of any age, is characterized by permanent dilation of bronchi due to inflammation and chronic infections.
This formulation has been used to decrease cough and alleviate pain.